Till F Omansen Selected Research

Till F Omansen Research Topics

6	Buruli Ulcer 10/2021 - 09/2013
3	Infections 10/2021 - 01/2017
3	Tuberculosis (Tuberculoses) 01/2019 - 03/2016
1	Cutaneous Leishmaniasis 09/2020
1	Takayasu Arteritis (Arteritis, Takayasu's) 09/2020
1	Leishmaniasis 09/2020
1	Lassa Fever (Fever, Lassa) 01/2020
1	Granuloma 12/2019
1	Body Weight (Weight, Body) 01/2019
1	Scabies (Sarcoptic Mange) 01/2018
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2018
1	Ototoxicity 03/2015
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 02/2015
1	Wounds and Injuries (Trauma) 01/2014

3	Pharmaceutical PreparationsIBA 10/2021 - 01/2018
3	Rifampin (Rifampicin)FDA LinkGeneric 01/2020 - 01/2019
2	telacebecIBA 10/2021 - 01/2020
2	Streptomycin (Streptomycin Sulfate)FDA Link 01/2019 - 03/2015
2	RifamycinsIBA 01/2019 - 01/2019
1	Infliximab (Remicade)FDA Link 09/2020
1	Interferon-gamma (Interferon, gamma)IBA 09/2020
1	Ribavirin (Virazole)FDA LinkGeneric 01/2020
1	Antitubercular AgentsIBA 01/2020
1	AcidsIBA 12/2019
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2019
1	Oxazolidinones (2 Oxazolidone)IBA 01/2019
1	Linezolid (Zyvox)FDA Link 01/2019
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	Ivermectin (Mectizan)FDA Link 01/2018
1	Clofazimine (Lamprene)FDA Link 01/2018
1	Permethrin (Ambush)FDA LinkGeneric 01/2018
1	Immunoglobulin G (IgG)IBA 02/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	NeopterinIBA 09/2013